GluA2 (AMPA2) Neurons

📖 Wiki Page

cell989 wordssynced 2026-04-02

GluA2 (AMPA2) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GluA2 (AMPA2) Neurons</th>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Variable</td>
</tr>
</table>

Introduction

Glua2 (Ampa2) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Neurons expressing the GRIA2 gene, which encodes the GluA2 subunit (also known as AMPA2) of AMPA receptors, represent a critical population in the central nervous system. The GluA2 subunit is uniquely characterized by itsedited Q/R site in the ion channel pore, which renders AMPA receptors calcium-impermeable [@hollmann1991]. This feature is essential for normal synaptic transmission, plasticity, and neuronal survival. The vast majority of neurons in the mature brain express GluA2-containing AMPA receptors, making these neurons fundamental to circuit function throughout the cortex, hippocampus, and cerebellum.

Molecular Biology of GluA2

...

GluA2 (AMPA2) Neurons

Introduction

Overview

Molecular Biology of GluA2

Gene and Protein Structure

The GRIA2 gene (also known as GluA2 or AMPA2) is located on chromosome 4q32.1 in humans and encodes a 906-amino acid protein [@gria]. The GluA2 subunit is a member of the ionotropic glutamate receptor family and contains several key structural features:

N-terminal domain: Mediates subunit assembly and ligand binding
Ligand-binding domain (LBD): Binds glutamate, the primary excitatory neurotransmitter
Transmembrane domains: Form the ion channel pore
C-terminal domain: Handles synaptic targeting and protein interactions

The critical feature of GluA2 is the Q/R site editing at position 607 (Q607R). This adenosine-to-inosine RNA editing event, catalyzed by the enzyme ADAR2, changes a glutamine (Q) to arginine (R) in the channel pore [@higuchi2000]. This arginine creates a positively charged ring that blocks calcium influx.

Alternative Splicing

The GRIA2 gene undergoes alternative splicing at two major sites:

Flip/Flop exon: The flip/flop splicing determines the rate of channel desensitization and affects synaptic plasticity [@mosbacher1994]

C-terminal splicing: Generates isoforms with different trafficking properties

Cellular Distribution

Brain Region Distribution

GluA2-expressing neurons are found throughout the central nervous system:

Cell Type Specificity

Most excitatory neurons in the cortex and hippocampus express high levels of GluA2. In contrast, some interneuron populations and specific subcortical nuclei may express calcium-permeable AMPA receptors lacking GluA2 [@isaac2007].

Function in Normal Physiology

Calcium-Impermeable AMPA Receptors

The primary function of GluA2 in neurons is to render AMPA receptors impermeable to calcium. This has several critical implications:

Synaptic stability: Prevents excessive calcium entry during normal synaptic transmission

Excitation-inhibition balance: Maintains appropriate firing rates

Metabolic efficiency: Reduces energy demands associated with calcium homeostasis

Synaptic Plasticity

GluA2-containing AMPA receptors are essential for synaptic plasticity, the cellular basis of learning and memory:

Long-term potentiation (LTP): GluA2 trafficking is required for LTPmechanisms/long-term-potentiation) induction
Long-term depression (LTD): Internalization of GluA2-containing receptors mediates LTD
Homeostatic plasticity: Activity-dependent regulation of GluA2 expression scales synaptic strength

Seizure Threshold

Neurons with GluA2 expression maintain higher seizure thresholds due to reduced excitability. The calcium-impermeable receptors prevent the positive feedback loop of calcium-induced excitotoxicity that can trigger seizure activity [@bradford2010].

Motor Learning

In the cerebellum, GluA2-expressing Purkinje cells and cerebellar granule cells are essential for motor learning and coordination. The precise calcium handling allowed by GluA2-containing receptors enables the error signals necessary for learning.

Role in Neurodegenerative Diseases

Alzheimer's Disease

GluA2 dysfunction is increasingly recognized in Alzheimer's disease pathophysiology:

Amyloid-Beta Effects:

Aβ oligomers reduce GluA2 surface expression [@parameshwaran2008]
This leads to increased calcium permeability and synaptic dysfunction
Promotes excitotoxicity and neuronal death

tau Pathology:

Hyperphosphorylated tau affects GluA2 trafficking
Impairs synaptic plasticity mechanisms
Contributes to cognitive decline

Therapeutic Implications:

Restoring GluA2 function is a potential therapeutic strategy
Agents that enhance GluA2 expression may protect synapses

Epilepsy

Alterations in GluA2 expression and editing are strongly implicated in epilepsy:

Reduced GluA2 Expression:

Found in epileptic tissue from patients with temporal lobe epilepsy
Results in calcium-permeable AMPA receptors
Creates hyperexcitable circuits

Q/R Site Editing Deficiency:

ADAR2 activity may be reduced in epilepsy
Unedited GluA2 (Q607) allows calcium influx
Contributes to seizure generation

Parkinson's Disease

While less studied than in AD, GluA2 dysfunction may play a role in Parkinson's disease:

Altered AMPA receptor subunit composition in the basal ganglia
Contributes to motor circuit dysfunction
May affect levodopa-induced dyskinesias

Amyotrophic Lateral Sclerosis (ALS)

Motor neurons in ALS show reduced GluA2 expression:

Leads to increased vulnerability to excitotoxicity
Contributes to motor neuron death
Suggests therapeutic potential for AMPA receptor antagonists

Therapeutic Targeting

Agonists and Positive Allosteric Modulators

AMPAkines: Compounds that enhance AMPA receptor function (e.g., CX516, CX717) may improve cognitive function by potentiating GluA2-containing receptors [@lynch2006]. These have been investigated for:

Alzheimer's disease
Cognitive enhancement
Depression

Antagonists

For conditions involving excessive excitation:

Perampanel: FDA-approved AMPA receptor antagonist for epilepsy
Talampanel: Investigational drug for ALS and Parkinson's disease

Gene Therapy

Viral vector delivery of GRIA2 is being explored:

Restore proper GluA2 expression
Protect neurons from excitotoxicity
Potential for neurodegenerative diseases
GRIA2 Gene
GRIA2 Protein
AMPA Receptor
Glutamate Receptors
[Cell Types Index](/cell-types) Cortex
Hippocampus
Cerebellum
[Alzheimer's Disease](/diseases/alzheimers-disease)
Epilepsy
[Parkinson's Disease](/diseases/parkinsons-disease)
Synaptic Plasticity
Excitotoxicity

Background

The study of Glua2 (Ampa2) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

NCBI Gene: [GRIA2](https://www.ncbi.nlm.nih.gov/gene/2891)
UniProt: [GluA2](https://www.uniprot.org/uniprot/P42262)
Ensembl: [GRIA2](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120251)
Allen Brain Atlas: [GRIA2 expression](https://human.brain-map.org/microarray/search/show?search_term=GRIA2)
PubMed: [GRIA2 neurodegeneration research](https://pubmed.ncbi.nlm.nih.gov/?term=GRIA2+neurodegeneration)

📖 View canonical wiki page →